EXTON, Pa., Feb. 27, 2013 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading global developer and manufacturer of components and systems for injectable drug delivery, announces ...

The global intradermal injection market size is expected to surpass an impressive valuation of USD 3,878 Million in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 10.8% from ...

Novel needle-free Intradermal (ID) delivery technologies provide effective alternatives to traditional Mantoux ID administration using needles. An in-depth review of 59 published scientific ...

If found to be safe and immunogenic, reduced doses of influenza vaccine given by the intradermal route could increase the number of available doses of vaccine. In an open-label study, we randomly ...

The adapter is designed to help improve the consistency and reliability of intradermal injections for vaccines and other injectable drugs. The system will complement West's portfolio of prefilled ...

A growing emphasis on dose-sparing strategies and equitable vaccine access has renewed global interest in ID vaccine delivery. A recent, peer-reviewed publication in Qeios 1 evaluated the evidence on ...